Anti-gpc3 and anti-cd137 multispecific antibodies and methods of use
US-2025154279-A1 · May 15, 2025 · US
This page is not indexed by search engines while we improve data quality.
Qu Liang patents
Qu Liang is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Qu Liang |
| Total patents | 21 |
| First publication | Oct 7, 2021 |
| Latest publication | May 15, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-CEA Antibody Drug Conjugates and Methods of Use
US-2025115677-A1 · Apr 10, 2025 · US
Circular rna vaccines and methods of use thereof
US-2025108134-A1 · Apr 3, 2025 · US
Circular rna vaccines against sars-cov-2 variants and methods of use thereof
US-2025082746-A1 · Mar 13, 2025 · US
MUC1 and CD16A Antibodies and Methods of Use
US-2025075002-A1 · Mar 6, 2025 · US
Single-pot methods for producing circular rnas
US-2025051816-A1 · Feb 13, 2025 · US
Targeted rna editing by leveraging endogenous adar using engineered rnas
US-2024309368-A1 · Sep 19, 2024 · US
Anti-gpc3 and anti-cd137 multispecific antibodies and methods of use
US-2024209113-A1 · Jun 27, 2024 · US
Anti-cd137 antibodies and methods of use
US-2024209106-A1 · Jun 27, 2024 · US
Anti-cea and anti-cd137 multispecific antibodies and methods of use
US-2024190989-A1 · Jun 13, 2024 · US
Recent patents
Latest publications not already listed above.
Anti-cea antibodies and methods of use
US-2024190990-A1 · Jun 13, 2024 · US
Targeted rna editing by leveraging endogenous adar using engineered rnas
US-2023365962-A1 · Nov 16, 2023 · US
Circular rna vaccines and methods of use thereof
US-2023346921-A1 · Nov 2, 2023 · US
Methods and compositions for editing RNAs
US-11702658-B2 · Jul 18, 2023 · US
Targeted RNA editing by leveraging endogenous ADAR using engineered RNAs
US-11661596-B2 · May 30, 2023 · US
Methods and compositions for editing rnas
US-2022307020-A1 · Sep 29, 2022 · US
Targeted rna editing by leveraging endogenous adar using engineered rnas
US-2022243194-A1 · Aug 4, 2022 · US
Targeted rna editing by leveraging endogenous adar using engineered rnas
US-2022135963-A1 · May 5, 2022 · US
Methods and compositions for editing rnas
US-2022098587-A1 · Mar 31, 2022 · US
Methods and compositions for editing rnas
US-2021355494-A1 · Nov 18, 2021 · US
Methods and compositions for editing rnas
US-2021310026-A1 · Oct 7, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Beijing | 14 |
| Beigene Switzerland Gmbh | 6 |
| Edigene Inc | 4 |
| Edigene Therapeutics Beijing Inc | 1 |
| Beijing Changping Laboratory | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/113 | 10 |
| C12N15/102 | 10 |
| A61P35/00 | 9 |
| C12Y305/04004 | 8 |
| C12N2310/11 | 8 |